Vaccination: History, Types, and Public Health Impact

Early History of Vaccination

Vaccination is a cornerstone of infectious disease prevention. Its origins trace back centuries, with early practices such as variolation and the pioneering work of Edward Jenner.

• Variolation: The deliberate introduction of material from smallpox lesions into an uninfected person, usually via the skin or nose, to induce a mild infection and subsequent immunity. Mortality rates were lower (1–2%) than natural smallpox infection, but risks remained.

• Edward Jenner (1796): Observed that milkmaids who contracted cowpox were protected from smallpox. He inoculated a boy with cowpox, who then became immune to smallpox, demonstrating cross-protection by a related, less dangerous pathogen.

• Louis Pasteur (late 1800s): Developed vaccines for rabies and anthrax, further advancing immunization science.

• Smallpox Eradication: By the 1970s, global vaccination campaigns led to the eradication of smallpox.

Controversies: Vaccination has faced opposition throughout history, from 19th-century antivaccination societies to modern misinformation campaigns. Notably, a 1998 study falsely linking MMR vaccine to autism was later retracted, but contributed to vaccine hesitancy and disease outbreaks.

Public Health Impact

• Vaccines have prevented millions of hospitalizations and deaths (e.g., 21 million hospitalizations and 732,000 deaths in the US from 1994–2013).

• High vaccination rates are essential for herd immunity, protecting those who cannot be vaccinated (e.g., immunocompromised, infants).

• Routine childhood and adult vaccines protect against over 25 infectious diseases.

Types of Vaccines and Their Characteristics

Live Attenuated Vaccines

Contain weakened but live pathogens that stimulate strong immune responses.

• Examples: MMR (measles, mumps, rubella), oral polio, varicella.

• Benefits: Induce potent, long-lasting immunity (both antibody and cellular responses).

• Drawbacks: Risk of causing disease in immunocompromised individuals or pregnant women; require refrigeration; rare risk of reversion to virulence.

Inactivated Vaccines

Contain killed pathogens, unable to replicate but still immunogenic.

• Examples: Inactivated polio vaccine, hepatitis A.

• Benefits: Safe for immunocompromised; stable at room temperature.

• Drawbacks: Weaker or shorter-lived immune response; require multiple doses and boosters.

Subunit Vaccines

Contain purified antigens or parts of the pathogen, not the whole organism.

• Types: Purified subunit, toxoid, conjugate, recombinant protein vaccines.

• Examples: Hepatitis B (recombinant), tetanus and diphtheria (toxoid), Hib and pneumococcal (conjugate).

• Benefits: Cannot cause infection; focused immune response.

• Drawbacks: Often require adjuvants to enhance immunogenicity.

DNA and mRNA Vaccines

Deliver genetic instructions for host cells to produce antigenic proteins, stimulating immunity.

• DNA Vaccines: Plasmid DNA encoding antigen is injected; host cells transcribe and translate the gene.

• mRNA Vaccines: mRNA is delivered directly and translated into protein antigen.

• Benefits: Induce both humoral and cellular immunity; rapid development and production.

Recombinant Vector Vaccines

Use harmless viruses or bacteria to deliver genetic material encoding antigens from the target pathogen.

• Examples: Adenovirus-based COVID-19 vaccines.

Vaccine Administration and Recommendations

• Vaccines can be administered orally (e.g., rotavirus), intramuscularly (e.g., Tdap), or intranasally (e.g., influenza nasal spray).

• Immunity develops over ~2 weeks post-vaccination as the adaptive immune system generates memory cells and antibodies.

• Some groups (pregnant women, immunocompromised) should avoid live attenuated vaccines due to safety concerns.

• Annual influenza vaccination is recommended due to antigenic drift and waning immunity.

• Special recommendations: Tdap in pregnancy (to protect newborns), pneumococcal and shingles vaccines for older adults.

Herd Immunity

Occurs when a high proportion of a population is immune, reducing disease transmission and protecting non-immune individuals. Thresholds vary by pathogen (e.g., ~95% for measles).

Vaccine Formulation Comparison Table

Immunological Diagnostics

Principles and Applications

Immunological diagnostics detect specific antigens or antibodies in patient samples, providing rapid and sensitive identification of infections or immune status.

• Serology: Study of antigen-antibody interactions in blood serum.

• Advantages: High sensitivity and specificity; faster than culture-based methods; can detect nonculturable pathogens.

• Applications: Diagnosis of infectious diseases, blood typing, detection of immune disorders.

Common Immunological Tests

• Agglutination Tests: Detect clumping of antigens and antibodies; used for blood typing and infection diagnosis (e.g., Treponema pallidum particle agglutination for syphilis).

• Enzyme-Linked Immunosorbent Assay (ELISA): Uses enzyme-labeled antibodies to detect antigens or antibodies. Formats include direct, indirect, and sandwich ELISA. In sandwich ELISA, the antigen is trapped between two antibodies.

• Immunofluorescence Microscopy: Uses fluorescent-tagged antibodies to visualize antigens under a specialized microscope.

Adjuvants in Vaccines

Adjuvants are substances added to vaccines to enhance the immune response to antigens. Common adjuvants include aluminum salts and monophosphoryl lipid A.

Molecular Methods in Microbiology

Polymerase Chain Reaction (PCR)

PCR is a sensitive technique for amplifying specific DNA sequences, enabling detection of pathogens and genetic analysis.

• Requirements: Template DNA, two primers, Taq polymerase, dNTPs.

• Steps:

  1. Denaturation (95–99°C): Double-stranded DNA separates.

  2. Annealing (50–65°C): Primers bind to target sequences.

  3. Extension (65–75°C): DNA polymerase synthesizes new DNA.

• Exponential Amplification: Number of DNA copies after n cycles:

• Real-time PCR (qPCR): Uses fluorescence to quantify DNA as it is amplified, providing immediate results and quantification of initial template.

Applications of PCR and Molecular Diagnostics

• Diagnosis of infectious diseases

• Genetic disorder screening

• Gene sequencing

Gene Therapy and CRISPR-Cas9

• Gene Therapy: Uses modified viruses (e.g., adenoviruses, retroviruses) as vectors to deliver therapeutic genes into patient cells. Delivery can be in vivo (direct to patient) or ex vivo (cells modified outside the body and returned).

• CRISPR-Cas9: A gene-editing tool derived from a prokaryotic immune system. CRISPR acts as a guide to locate specific DNA sequences, while Cas9 acts as molecular scissors to cut DNA, allowing insertion or removal of genetic material.

Ethical and Legal Considerations

• Genetic Information Nondiscrimination Act (GINA, 2008): Protects individuals from discrimination based on genetic information, though some loopholes remain for insurers and employers.

Summary Table: Diagnostic Methods

Key Terms and Definitions

• Antigen: A molecule capable of inducing an immune response.

• Antibody: A protein produced by B cells that binds specifically to an antigen.

• Adjuvant: A substance that enhances the body's immune response to an antigen.

• Serology: The study of antigen-antibody interactions in serum.

• Herd Immunity: Indirect protection from infectious disease when a large percentage of a population is immune.

• CRISPR-Cas9: A gene-editing technology derived from a bacterial immune system.

• Gene Therapy: The introduction, removal, or alteration of genetic material within a person's cells to treat disease.